August 2024—Sysmex America announced on July 9 that longtime health care executive Dan Zortman has been named the company’s new CEO. Andy Hay, who has served as CEO since 2021, will continue to serve as chairman and president of Sysmex America with a focus on the company’s emerging Hinotori surgical robotic system business.
Zortman is a diagnostics industry executive with more than 33 years of experience. He has worked at Roche for the past 24 years, most recently as senior vice president of commercial operations, successfully leading the company to achieve its No. 1 position in the U.S. market. Zortman has also held several global sales and marketing leadership positions and served as national director of sales and marketing for Roche Canada and as a regional business manager in the northeast territory. Before joining Roche, he worked in sales at Pharmacia Dx, Sanofi (now part of Beckman), Bio-Rad, and Chiron (now part of Siemens).
“It’s an honor to join Sysmex America, a trusted global leader respected for optimizing the efficiency, operations, and financial performance of clinical laboratories,” Zortman said in a press statement. “As the health care landscape transforms from volume to value, Sysmex America will have more opportunities to further its commitment to equipping patients and the health care professionals who treat them with the information needed to make decisions with greater trust and confidence. My focus will be to meet the moment while staying true to our core purpose.”
“Dan is exceptionally well-suited to advance our long-term strategy and accelerate growth,” said Andy Hay. “He is a strategic and customer-focused leader who understands our organization’s deep sense of purpose. We have a strong transition plan at work, and I look forward to working alongside him as he enables further success for Sysmex America.”
Sysmex America, 847-367-3503